Language selection

Government of Canada / Gouvernement du Canada

Search

Supplemental statement - recombinant influenza vaccines : Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2022-2023.: HP5-140/2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.913162&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
  • Canada. National Advisory Committee on Immunization, issuing body.
TitleSupplemental statement - recombinant influenza vaccines : Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2022-2023.
Variant title
  • Supplemental statement - quadrivalent recombinant influenza vaccines
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Déclaration supplémentaire - vaccins antigrippaux recombinants : chapitre sur la grippe du guide canadien d'immunisation et déclaration sur la vaccination antigrippale pour la saison 2022-2023.
  • Cover title.
  • On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
  • "Pub.: 220317."
  • Issued also in HTML format.
  • Includes bibliographical references (pages 51-54).
Publishing information
  • [Ottawa] : Public Health Agency of Canada = Agence de la santé publique du Canada, September 2022.
  • ©2022
Description1 online resource (57 pages) : illustration
ISBN9780660444864
Catalogue number
  • HP5-140/2022E-PDF
Departmental catalogue number220317
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: